נרבן ישראל - עברית - Ministry of Health

נרבן

neopharm (israel) 1996 ltd - hawthorn leaf and flower native extract; hop native extract; passion flower howthorn berries (2.8:1) native extract; valerian native extract - דרז'ה - valerian native extract 67.5 mg; hop native extract 29.4 mg; passion flower howthorn berries (2.8:1) native extract 81 mg; hawthorn leaf and flower native extract 81 mg - other hypnotics and sedatives - sedative, anxiety and tension states, insomnia.

אולטיברו בריזהלר 11050 מקג ישראל - עברית - Ministry of Health

אולטיברו בריזהלר 11050 מקג

novartis israel ltd - glycopyrronium as bromide; indacaterol as maleate - אבקה לשאיפה בקפסולות קשיחות - indacaterol as maleate 110 mcg; glycopyrronium as bromide 50 mcg - indacaterol

אקספורג' 5 מג 80 מג ישראל - עברית - Ministry of Health

אקספורג' 5 מג 80 מג

novartis israel ltd - amlodipine as besylate; valsartan - טבליות מצופות פילם - amlodipine as besylate 5 mg; valsartan 80 mg - amlodipine - amlodipine - treatment of essential hypertension. exforge is indicated for patients whose blood pressure is not adequately controlled on monotherapy.

אקספורג' 5 מג 160 מג ישראל - עברית - Ministry of Health

אקספורג' 5 מג 160 מג

novartis israel ltd - amlodipine as besylate; valsartan - טבליות מצופות פילם - amlodipine as besylate 5 mg; valsartan 160 mg - amlodipine - amlodipine - treatment of essential hypertension. exforge is indicated for patients whose blood pressure is not adequately controlled on monotherapy.

אקספורג' 10 מג 160 מג ישראל - עברית - Ministry of Health

אקספורג' 10 מג 160 מג

novartis israel ltd - amlodipine as besylate; valsartan - טבליות מצופות פילם - amlodipine as besylate 10 mg; valsartan 160 mg - amlodipine - amlodipine - treatment of essential hypertension. exforge is indicated for patients whose blood pressure is not adequately controlled on monotherapy.

דיובאן 80 מג טבליות מצופות ישראל - עברית - Ministry of Health

דיובאן 80 מג טבליות מצופות

novartis israel ltd - valsartan - טבליות מצופות פילם - valsartan 80 mg - valsartan - valsartan - for treatment of hypertension. diovan is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial diovan signicantly reduced hospitalisations for heart failure. there is no evidence that diovan provides added benefits when it is used with an adequate dose of an ace inhibitor. diovan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.

דיובאן 160 מג טבליות מצופות ישראל - עברית - Ministry of Health

דיובאן 160 מג טבליות מצופות

novartis israel ltd - valsartan - טבליות מצופות פילם - valsartan 160 mg - valsartan - valsartan - for treatment of hypertension. diovan is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial diovan signicantly reduced hospitalisations for heart failure. there is no evidence that diovan provides added benefits when it is used with an adequate dose of an ace inhibitor. diovan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.

דיובאן   40 מג טבליות מצופות ישראל - עברית - Ministry of Health

דיובאן 40 מג טבליות מצופות

novartis israel ltd - valsartan - טבליות מצופות פילם - valsartan 40 mg - valsartan - valsartan - diovan is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial diovan significantly reduced hospitalisations for heart failure. there is no evidence that diovan provides added benefits when it is used with an adequate dose of an ace inhibitor. diovan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.